🇸🇪 Sweden Country × Condition
myelodysplastic syndromes Clinical Trials in Sweden
Active clinical trials for myelodysplastic syndromes with research sites in Sweden. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇸🇪 Sweden
Active Trials in Sweden (2)
NCT05788679 Phase 2
Recruiting
A Study Using Subject-specific MRD to Adopt Treatment After HSCT for Subjects With MDS
Enrollment
200 pts
Country
🇸🇪 Sweden
Karolinska University Hospital
View Trial → NCT03999723 Phase 2
Recruiting
Combining Active and Passive DNA Hypomethylation
Enrollment
196 pts
Country
🇸🇪 Sweden
Kirsten Grønbæk
View Trial → Frequently Asked Questions
How many myelodysplastic syndromes clinical trials are active in Sweden?
There are currently 2 active clinical trials for myelodysplastic syndromes with sites in Sweden, of which 2 are actively recruiting patients.
How can I join a myelodysplastic syndromes clinical trial in Sweden?
To join a myelodysplastic syndromes clinical trial in Sweden, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Sweden directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are myelodysplastic syndromes trials in Sweden?
Active myelodysplastic syndromes trials in Sweden span Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology